Join
Live feed
·
NEWSReleasevia Quantisnow
Aspire Biopharma Holdings Inc. logo

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

ByQuantisnow·Wall Street's wire, on your screen.
ASBP· Aspire Biopharma Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ASBP (Aspire Biopharma Holdings Inc.) and more on Quantisnow.